Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: Data from CHECK, a cohort study of early osteoarthritis

Annals of the Rheumatic Diseases

Volumn 72, Issue 1, 2013, Pages 29-36

  Van Spil, Willem E ^a   Drossaers Bakker, K Wiepke ^b   Lafeber, Floris P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; CHONDROITIN SULFATE 846; OSTEOCALCIN; PROCOLLAGEN; TYPE 1 PROCOLLAGEN AMINOTERMINAL PROPEPTIDE; TYPE II A COLLAGEN PROPEPTIDE; TYPE II COLLAGEN C TERMINAL TELOPEPTIDE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BONE DEFECT; BONE METABOLISM; BONE TURNOVER; CARTILAGE DEGENERATION; CARTILAGE METABOLISM; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOARTHRITIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEX DIFFERENCE; TISSUE METABOLISM; TISSUE SPECIFICITY;

AGED; BIOLOGICAL MARKERS; BONE REMODELING; CARTILAGE; COHORT STUDIES; COLLAGEN TYPE II; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; RADIOIMMUNOASSAY;

EID: 84871088548     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-201177     Document Type: Article

References (49)

1. Charni N, Juillet F, Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2005;52:1081-90. (Pubitemid 40530115)
2. Eyre DR, Weis MA. The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence. Osteoarthr Cartil 2009; 17 :423-6.
3. Hedbom E, Antonsson P, Hjerpe A, et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992;267:6132-6.
4. DiCesare P, Hauser N, Lehman D, et al. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 1994;354:237-40. (Pubitemid 24335515)
5. Di Cesare PE, Fang C, Leslie MP, et al. Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage. J Orthop Res 1999;17:437-45. (Pubitemid 29275429)
6. Christgau S, Garnero P, Fledelius C, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15. (Pubitemid 32823562)
7. Wesseling J, Dekker J, van den Berg WB, et al. CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. Ann Rheum Dis 2009;68:1413-19.
8. Norlund LL, Shao P, Yoshihara P, et al. Markers of bone type I and cartilage type II collagen degradation in the Hartley guinea pig model of osteoarthritis. In: Orthopedic Research Society, 43rd Annual Meeting. San Francisco, California 1997.
9. Ardawi MS, Maimani AA, Bahksh TA, et al. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study. Bone 2010;47:804-14.
10. Cifuentes M, Johnson MA, Lewis RD, et al. Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women. Osteoporos Int 2003;14:116-22. (Pubitemid 40824226)
11. Nelson AE, Howe CJ, Nguyen TV, et al. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes. J Clin Endocrinol Metab 2006;91:4424-32. (Pubitemid 44833418)
12. Otterness IG, Swindell AC, Zimmerer RO, et al. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthr Cartil 2000;8:180-5. (Pubitemid 30304185)
13. Karsdal MA, Byrjalsen I, Bay-Jensen AC, et al. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis-the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation. BMC Musculoskelet Disord 2010;11:125.
14. Glover SJ, Garnero P, Naylor K, et al. Establishing a reference range for bone turnover markers in young, healthy women. Bone 2008;42:623-30.
15. Garnero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26. (Pubitemid 32493990)
16. Adami S, Bianchi G, Brandi ML, et al.; BONTURNO study group. Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 2008; 82:341-7.
17. Trento LK, Pietropolli A, Ticconi C, et al. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J Obstet Gynaecol Res 2009;35:152-9.
18. Scariano JK, Garry PJ, Montoya GD, et al. Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women. Mech Ageing Dev 2003;124:281-6. (Pubitemid 36351587)
19. Wisłowska M, Jakubicz D, Stepien' K, et al. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis. Rheumatol Int 2009;29:1403-9.
20. Magni P, Dozio E, Galliera E, et al. Molecular aspects of adipokine-bone interactions. Curr Mol Med 2010;10:522-32.
21. Karsenty G, Oury F. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J Clin Endocrinol Metab 2010;95:4795-801.
22. Donescu OS, Battié MC, Videman T, et al. Anthropometrics and biochemical markers in men. J Clin Densitom 2005;8:222-7. (Pubitemid 41411253)
23. Iki M, Akiba T, Matsumoto T, et al.; JPOS Study Group. Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int 2004;15:981-91. (Pubitemid 40064653)
24. Pi YZ, Wu XP, Liu SP, et al. Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women. J Bone Miner Metab 2006;24:380-5.
25. Minisola S, Dionisi S, Pacitti MT, et al. Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 2002;13:171-5. (Pubitemid 34241037)
26. Yan L, Prentice A, Zhou B, et al. Age- and gender-related differences in bone mineral status and biochemical markers of bone metabolism in Northern Chinese men and women. Bone 2002;30:412-15. (Pubitemid 34150165)
27. Tanishi N, Yamagiwa H, Hayami T, et al. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey. J Bone Miner Metab 2009;27:605-12.
28. Alexandersen P, Karsdal MA, Byrjalsen I, et al. Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis. Climacteric 2011;14:236-43.
29. Davis CR, Karl J, Granell R, et al. Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum 2007;56:4038-47. (Pubitemid 350262331)
30. Jordan KM, Syddall HE, Garnero P, et al. Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 2006;65:871-7.
31. Kraus VB, Kepler TB, Stabler T, et al. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS ONE 2010;5:e9739.
32. Mazières B, Hucher M, Zaïm M, et al. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 2007;66:639-45. (Pubitemid 46707133)
33. Rousseau JC, Chevrel G, Schott AM, et al. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations. Bone 2010;46:897-900.
34. Bingham CO 3rd, Buckland-Wright JC, Garnero P, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006;54:3494-507. (Pubitemid 44737161)
35. Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, et al. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthr Cartil 2008;16:615-23. (Pubitemid 351545558)
36. Di Cesare PE, Carlson CS, Stolerman ES, et al. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res 1996;14:946-55. (Pubitemid 27044464)
37. van Spil WE, DeGroot J, Lems WF, et al. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthr Cartil 2010;18:605-12.
38. Karsdal MA, Byrjalsen I, Leeming DJ, et al. Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation. BMC Musculoskelet Disord 2008;9 :153.
39. Huebner JL, Hanes MA, Beekman B, et al. A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthr Cartil 2002;10:758-67. (Pubitemid 35153716)
40. Pickarski M, Hayami T, Zhuo Y, et al. Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. BMC Musculoskelet Disord 2011;12:197.
41. Brennan SL, Pasco JA, Cicuttini FM, et al. Bone mineral density is cross sectionally associated with cartilage volume in healthy, asymptomatic adult females: Geelong Osteoporosis Study. Bone 2011;49:839-44.
42. Nakamae A, Engebretsen L, Bahr R, et al. Natural history of bone bruises after acute knee injury: clinical outcome and histopathological findings. Knee Surg Sports Traumatol Arthrosc 2006;14:1252-8. (Pubitemid 44800651)
43. Dore D, Martens A, Quinn S, et al. Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther 2010;12:R222.
44. Strassle BW, Mark L, Leventhal L, et al. Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthr Cartil 2010;18:1319-28.
45. Hashimoto J, Garnero P, van der Heijde D, et al. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs. Mod Rheumatol 2009;19:273-82.
46. Freeston JE, Garnero P, Wakefield RJ, et al. Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis. Ann Rheum Dis 2011;70:331-3.
47. Ishikawa T, Nishigaki F, Christgau S, et al. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments. J Rheumatol 2004;31:1174-9. (Pubitemid 38715895)
48. van Tuyl LH, Voskuyl AE, Boers M, et al. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis 2010;69:1623-8.
49. Van Spil WE, Jansen NW, Bijlsma JW, et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartil (in press).